Mammalian cell factories for efficient and stable protein expression

Area of Science:

• Biotechnology
• Molecular Biology
• Cell Biology

Background:

• The growing market for therapeutic proteins necessitates enhanced production efficiency and stability in mammalian cell systems.
• Understanding the molecular environment of transgenes within chromatin, including epigenetic modifications, is crucial for optimizing protein expression.
• The 'omics' revolution provides powerful tools for identifying complex regulatory factors influencing transgene expression.

Purpose of the Study:

• To explore recent advancements in understanding and manipulating the molecular environment of transgenes for improved protein production.
• To leverage 'omics' data for rational cell engineering strategies.
• To enhance the translational and secretory capacity of host cells for therapeutic protein manufacturing.

Main Methods:

• Investigating epigenetic modifications and their impact on transgene expression.
• Utilizing 'omics' technologies (genomics, transcriptomics, proteomics, etc.) to identify key regulatory elements.
• Applying directed cell engineering approaches based on 'omics' findings.

Main Results:

• Elucidation of the role of epigenetic modifications in controlling gene expression from transgenes.
• Identification of complex control factors governing transgene information flow through 'omics' analyses.
• Successful engineering of host cells to improve protein translation and secretion.

Conclusions:

• Recent advances in understanding chromatin and 'omics' data enable rational enhancement of therapeutic protein production.
• Directed cell engineering strategies informed by molecular insights offer improved routes for protein manufacturing.
• Future protein production will benefit from integrated approaches combining epigenetic knowledge and 'omics'-driven cell engineering.